Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus.

Kim, Ji Min; Joung, Kyong Hye; Lee, Jun Choul; Choung, Sorim; Kang, Seon Mee; Kim, Hyun Jin; Ku, Bon Jeong

Kim, Ji Min; Joung, Kyong Hye; Lee, Jun Choul; Choung, Sorim; Kang, Seon Mee; Kim, Hyun Jin; Ku, Bon Jeong.

Afiliação

Kim JM; Department of Endocrinology, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
Joung KH; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Lee JC; Department of Endocrinology, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.
Choung S; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Kang SM; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Kim HJ; Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Ku BJ; Department of Internal Medicine, Busan Paik Hospital, College of Medicine, Inje University, Busan, South Korea.

Ann Transl Med ; 9(21): 1612, 2021 Nov.

Article em En | MEDLINE | ID: mdl-34926656

Palavras-chave

Type 2 diabetes mellitus; biomarkers; human; leucine-rich repeats and immunoglobulin like domains 2 (LRIG2)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Screening_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google